Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT04051827 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung
Lung Neoplasms

Interventions

DRUG: Midazolam
DRUG: TAK-788

Sponsor

Millennium Pharmaceuticals, Inc.